153 related articles for article (PubMed ID: 29316907)
1. Expression of MMP-9 decreases metastatic potential of Chondrosarcoma: an immunohistochemical study.
Malcherczyk D; Heyse TJ; El-Zayat BF; Kunzke V; Moll R; Fuchs-Winkelmann S; Paletta JRJ
BMC Musculoskelet Disord; 2018 Jan; 19(1):9. PubMed ID: 29316907
[TBL] [Abstract][Full Text] [Related]
2. Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma.
Berend KR; Toth AP; Harrelson JM; Layfield LJ; Hey LA; Scully SP
J Bone Joint Surg Am; 1998 Jan; 80(1):11-7. PubMed ID: 9469303
[TBL] [Abstract][Full Text] [Related]
3. Expression of Matrix Metalloproteinase-9 and CD34 in Giant Cell Tumor of Bone.
Zhou X; Liu XZ; Fan GT; Wu SJ; Zhao JN; Shi X
Orthop Surg; 2016 May; 8(2):220-5. PubMed ID: 27384731
[TBL] [Abstract][Full Text] [Related]
4. Expression of aurora kinase A and B in chondrosarcoma and its relationship with the prognosis.
Liang X; Wang D; Wang Y; Zhou Z; Zhang J; Li J
Diagn Pathol; 2012 Jul; 7():84. PubMed ID: 22809428
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.
Gong J; Zhao Y; Abdel-Fattah R; Amos S; Xiao A; Lopes MB; Hussaini IM; Laws ER
Pituitary; 2008; 11(1):37-48. PubMed ID: 17768685
[TBL] [Abstract][Full Text] [Related]
6. Correlation between the histological grade of chondrosarcoma and the expression of MMPs, ADAMTSs and TIMPs.
Sugita H; Osaka S; Toriyama M; Osaka E; Yoshida Y; Ryu J; Sano M; Sugitani M; Nemoto N
Anticancer Res; 2004; 24(6):4079-84. PubMed ID: 15736455
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic relevance of the immunohistochemical detection of growth factors in benign and malignant cartilaginous tumors.
Falcone G; Rossi ED; Maccauro G; de Santis V; Rosa MA; Capelli A; Fadda G
Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):334-40. PubMed ID: 16932026
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of matrix metalloproteinase-3 in human osteosarcoma and its association with tumor metastasis.
Huang JF; Du WX; Chen JJ
J BUON; 2016; 21(5):1279-1286. PubMed ID: 27837634
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of matrix metalloproteinase-1, -3, and -13 in naturally occurring cartilaginous tumors of dogs.
Kuroki K; Kreeger JM; Cook JL; Tomlinson JL; Johnson GC; Pace LW; Turnquist SE; Turk JR; Ramos JA; Miller MA
Am J Vet Res; 2002 Sep; 63(9):1285-91. PubMed ID: 12224862
[TBL] [Abstract][Full Text] [Related]
10. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
11. The role of MMP-2 and MMP-9 as prognostic markers in the early stages of tongue squamous cell carcinoma.
Aparna M; Rao L; Kunhikatta V; Radhakrishnan R
J Oral Pathol Med; 2015 May; 44(5):345-52. PubMed ID: 25212455
[TBL] [Abstract][Full Text] [Related]
12. Fluid shear promotes chondrosarcoma cell invasion by activating matrix metalloproteinase 12 via IGF-2 and VEGF signaling pathways.
Wang P; Chen SH; Hung WC; Paul C; Zhu F; Guan PP; Huso DL; Kontrogianni-Konstantopoulos A; Konstantopoulos K
Oncogene; 2015 Aug; 34(35):4558-69. PubMed ID: 25435370
[TBL] [Abstract][Full Text] [Related]
13. The clinical pathological significance of FRAT1 and ROR2 expression in cartilage tumors.
He L; Yang Z; Zhou J; Wang W
Clin Transl Oncol; 2015 Jun; 17(6):438-45. PubMed ID: 25387569
[TBL] [Abstract][Full Text] [Related]
14. Role of matrix metalloproteinase (MMP) 2 and MMP-9 in soft tissue sarcoma.
Yang HK; Jeong KC; Kim YK; Jung ST
Clin Orthop Surg; 2014 Dec; 6(4):443-54. PubMed ID: 25436070
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma.
Häckel CG; Krueger S; Grote HJ; Oshiro Y; Hodges S; Johnston DA; Johnson ME; Roessner A; Ayala AG; Czerniak B
Cancer; 2000 Sep; 89(5):995-1003. PubMed ID: 10964329
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J
Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148
[TBL] [Abstract][Full Text] [Related]
17. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
[TBL] [Abstract][Full Text] [Related]
18. [Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].
He DS; Chen MZ; Wang HJ; Ke CL; Yan C; Zheng H; Hong YS
Ai Zheng; 2002 Oct; 21(10):1124-8. PubMed ID: 12508658
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.
Samantaray S; Sharma R; Chattopadhyaya TK; Gupta SD; Ralhan R
J Cancer Res Clin Oncol; 2004 Jan; 130(1):37-44. PubMed ID: 14569466
[TBL] [Abstract][Full Text] [Related]
20. Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas.
Kawashima A; Okada Y; Nakanishi I; Ueda Y; Iwata K; Roessner A
Gen Diagn Pathol; 1997 Feb; 142(3-4):129-37. PubMed ID: 9065576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]